List of insiders holdings for InMed Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Cutler Adam D. Director |
2022-01-24 16:17:00 | 95,335 0 |
95,335 | Form 4 |
2 | Tegge Jonathan Interim CFO |
2023-12-26 13:08:36 | 31,400 0 |
31,400 | Form 4 |
3 | Sazdanoff Catherine Director |
2021-12-30 18:03:21 | 29,091 0 |
29,091 | Form 4 |
4 | Garner William J Director |
2022-01-24 16:19:27 | 16,122 0 |
16,122 | Form 4 |
5 | ADAMS ERIC A President & CEO |
2024-12-23 09:20:10 | 14,300 0 |
14,300 | Form 4 |
6 | COLWILL BRUCE CFO |
2022-01-24 14:02:34 | 11,515 0 |
11,515 | Form 4 |
7 | WOUDENBERG MICHAEL Chief Operating Officer |
2024-12-23 09:24:14 | 7,505 0 |
7,505 | Form 4 |
8 | Jagpal Netta Chief Financial Officer |
2024-12-23 09:26:50 | 6,250 0 |
6,250 | Form 4 |
9 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev |
2024-12-23 09:21:36 | 5,350 0 |
5,350 | Form 4 |
10 | Li Sarah VP Accounting & Controller |
2022-12-19 17:03:37 | 4,002 0 |
4,002 | Form 4 |
11 | Johnson Shane Aaron Sr VP & General Manager |
2024-12-23 09:28:12 | 3,900 0 |
3,900 | Form 4 |
12 | HULL ANDREW Director |
2025-02-03 08:49:05 | 975 0 |
975 | Form 4 |
13 | Lemerond Nicole Director |
2024-12-23 09:25:28 | 975 0 |
975 | Form 4 |
14 | Grove Janet P Director |
2024-12-23 09:22:58 | 975 0 |
975 | Form 4 |
15 | Baldasare Bryan T Director |
2024-12-23 09:18:56 | 975 0 |
975 | Form 4 |
16 | MANCINI ALEXANDRA DIANE JANET Consultant |
2024-08-02 16:02:46 | 0 0 |
0 | Form 4 |
17 | Edwards Brenda Interim CFO |
2022-04-08 15:07:55 | 0 0 |
0 | Form 3 |